1461685-58-4

Upstream product

• 79200-56-9 (-)-2-azabicyclo[2.2.1]hept-5-en-3-one 
• 1461685-55-1 (2R,3aR,6aR)-benzyl 2-((3S,4S)-3-methoxytetrahydro-2H-pyran-4-ylamino)octahydropentalene-3a-carboxylate 
• 407-25-0 trifluoroacetic anhydride 
• 1461685-52-8 (2R,3aR,6aR)-2-((3S)-3-methoxytetrahydro-2H-pyran-4-ylamino)octahydropentalene-3a-carboxylic acid 
• 100-51-6 benzyl alcohol 
• 426226-35-9 (+)-methyl (1R,4S)-4-aminocyclopent-2-ene-1-carboxylate hydrochloride 
• 1461685-51-7 (2R,3aR,6aR)-methyl 2-((3S)-3-methoxytetrahydro-2H-pyran-4-ylamino)octahydropentalene-3a-carboxylate 
• 1461685-48-2 (2R,3aR,6aR)-methyl 2-aminooctahydropentalene-3a-carboxylate 
• 851916-41-1 (R)-3-methoxydihydro-2H-pyran-4(3H)-one 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 1421065-67-9 (2R,3aR,6aR)-methyl 2-(2,5-dimethyl-1H-pyrrol-1-yl)octahydropentalene-3a-carboxylate 
• 1461685-29-9 (1R,4S)-methyl 1-(3-bromopropyl)-4-(2,5-dimethyl-1H-pyrrol-1-yl)cyclopent-2-enecarboxylate 
• 851916-44-4 (1R,4S)-methyl 4-(2,5-dimethyl-1H-pyrrol-1-yl)cyclopent-2-enecarboxylate 

Relevant academic research and scientific papers

CHEMOKINE RECEPTOR ANTAGONISTS

Disclosed herein are chemokine receptor antagonists of formula (I) wherein R1, R2, and R3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using

CHEMOKINE RECEPTOR ANTAGONISTS

Disclosed herein are chemokine receptor antagonists of formula (I) wherein R1, R2, and R3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using